首页> 美国卫生研究院文献>PLoS Neglected Tropical Diseases >Loss in lung volume and changes in the immune response demonstrate disease progression in African green monkeys infected by small-particle aerosol and intratracheal exposure to Nipah virus
【2h】

Loss in lung volume and changes in the immune response demonstrate disease progression in African green monkeys infected by small-particle aerosol and intratracheal exposure to Nipah virus

机译:肺体积的减少和免疫反应的改变表明非洲绿猴的疾病进展受到小颗粒气溶胶和气管内暴露于尼帕病毒的感染

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nipah virus (NiV) is a paramyxovirus (genus Henipavirus) that emerged in the late 1990s in Malaysia and has since been identified as the cause of sporadic outbreaks of severe febrile disease in Bangladesh and India. NiV infection is frequently associated with severe respiratory or neurological disease in infected humans with transmission to humans through inhalation, contact or consumption of NiV contaminated foods. In the work presented here, the development of disease was investigated in the African Green Monkey (AGM) model following intratracheal (IT) and, for the first time, small-particle aerosol administration of NiV. This study utilized computed tomography (CT) and magnetic resonance imaging (MRI) to temporally assess disease progression. The host immune response and changes in immune cell populations over the course of disease were also evaluated. This study found that IT and small-particle administration of NiV caused similar disease progression, but that IT inoculation induced significant congestion in the lungs while disease following small-particle aerosol inoculation was largely confined to the lower respiratory tract. Quantitative assessment of changes in lung volume found up to a 45% loss in IT inoculated animals. None of the subjects in this study developed overt neurological disease, a finding that was supported by MRI analysis. The development of neutralizing antibodies was not apparent over the 8–10 day course of disease, but changes in cytokine response in all animals and activated CD8+ T cell numbers suggest the onset of cell-mediated immunity. These studies demonstrate that IT and small-particle aerosol infection with NiV in the AGM model leads to a severe respiratory disease devoid of neurological indications. This work also suggests that extending the disease course or minimizing the impact of the respiratory component is critical to developing a model that has a neurological component and more accurately reflects the human condition.
机译:Nipah病毒(NiV)是副粘病毒(Henipavirus的一种),在1990年代后期在马来西亚出现,此后被确定为孟加拉国和印度零星爆发严重高热病的原因。在受感染的人中,NiV感染通常与严重的呼吸道或神经系统疾病有关,并通过吸入,接触或食用受NiV污染的食物传播给人。在此处介绍的工作中,在气管内(IT)以及首次对NiV进行小颗粒气雾给药后,在非洲绿猴(AGM)模型中研究了疾病的发展。这项研究利用计算机断层扫描(CT)和磁共振成像(MRI)来临时评估疾病进展。还评估了宿主在疾病过程中的免疫反应和免疫细胞群的变化。这项研究发现,IT和NiV的小颗粒给药引起相似的疾病进展,但是IT接种会引起肺部严重充血,而小颗粒气雾剂接种后的疾病则主要局限于下呼吸道。肺体积变化的定量评估发现,接种IT的动物损失高达45%。这项研究中没有一个受试者出现明显的神经系统疾病,这一发现得到了MRI分析的支持。在疾病的8-10天中,中和抗体的发展并不明显,但是在所有动物中细胞因子反应的改变以及活化的CD8 + T细胞数量表明细胞介导的免疫开始。这些研究表明,AGM模型中的IT和NiV的小颗粒气溶胶感染会导致严重的呼吸系统疾病,而没有神经系统的适应症。这项工作还表明,扩大疾病进程或最大程度地减少呼吸系统的影响对于开发具有神经系统成分并更准确地反映人类状况的模型至关重要。

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号